Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response

UK COVIDsortium Investigators, João B. Augusto

Resultado de pesquisarevisão de pares

6 Citações (Scopus)

Resumo

Determining the protection an individual has to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VoCs) is crucial for future immune surveillance, vaccine development, and understanding of the changing immune response. We devised an informative assay to current ELISA-based serology using multiplexed, baited, targeted proteomics for direct detection of multiple proteins in the SARS-CoV-2 anti-spike antibody immunocomplex. Serum from individuals collected after infection or first- and second-dose vaccination demonstrates this approach and shows concordance with existing serology and neutralization. Our assays show altered responses of both immunoglobulins and complement to the Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.1) VoCs and a reduced response to Omicron (B1.1.1529). We were able to identify individuals who had prior infection, and observed that C1q is closely associated with IgG1 (r > 0.82) and may better reflect neutralization to VoCs. Analyzing additional immunoproteins beyond immunoglobulin (Ig) G, provides important information about our understanding of the response to infection and vaccination.

Idioma originalEnglish
Número do artigo100279
RevistaCell Reports Methods
Volume2
Número de emissão9
DOIs
Estado da publicaçãoPublicado - 19 set. 2022
Publicado externamenteSim

Impressão digital

Mergulhe nos tópicos de investigação de “Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response“. Em conjunto formam uma impressão digital única.

Citação